1
|
Pollak RM, Burrell TL, Cubells JF, Klaiman C, Murphy MM, Saulnier CA, Walker EF, White SP, Mulle JG. Visual-Motor Integration Deficits in 3q29 Deletion Syndrome. J Autism Dev Disord 2024; 54:3142-3154. [PMID: 37354284 PMCID: PMC11300491 DOI: 10.1007/s10803-023-06034-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/31/2023] [Indexed: 06/26/2023]
Abstract
3q29 deletion syndrome (3q29del) is associated with neuropsychiatric and neurodevelopmental phenotypes. We previously reported that graphomotor weakness is present in up to 78% of individuals with 3q29del. We have now explored nuances of the graphomotor phenotype and its association with other comorbidities in this population. Participants were recruited from the online 3q29 registry (3q29deletion.org) for two days of deep phenotyping. 32 individuals with 3q29del (62.5% male) were evaluated with the Beery-Buktenica Developmental Test of Visual-Motor Integration (VMI) to assess visual-motor integration. Participants were also evaluated with measures of cognitive ability, executive function, adaptive behavior, and school function. Males with 3q29del performed significantly worse than females on the VMI and Motor Coordination subtest. VMI performance was significantly associated with ADHD diagnosis and cognitive ability. Compared to published data from individuals with 22q11.2 deletion syndrome, individuals with 3q29del showed significantly more impairment. The 3q29 deletion is associated with substantial deficits in visual-motor integration, Visual Perception, and Motor Coordination. Our data suggests that 3q29del may qualify as a nonverbal learning disability. Future studies should assess whether individuals with 3q29del would benefit from early interventions, including occupational therapy.
Collapse
Affiliation(s)
- Rebecca M Pollak
- Center for Advanced Biotechnology and Medicine and Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, 679 Hoes Lane West, Piscataway, NJ, 08854, USA
| | - T Lindsey Burrell
- Department of Pediatrics, School of Medicine, Emory University, Atlanta, USA
| | - Joseph F Cubells
- Department of Human Genetics, School of Medicine, Emory University, Atlanta, USA
- Department of Psychiatry and Behavioral Science, School of Medicine, Emory University, Atlanta, USA
| | - Cheryl Klaiman
- Department of Pediatrics, School of Medicine, Emory University, Atlanta, USA
- Marcus Autism Center, Children's Healthcare of Atlanta and Emory University, Atlanta, USA
| | - Melissa M Murphy
- Department of Pediatrics, School of Medicine, Emory University, Atlanta, USA
| | - Celine A Saulnier
- Department of Pediatrics, School of Medicine, Emory University, Atlanta, USA
- Neurodevelopmental Assessment & Consulting Services, Decatur, USA
| | | | - Stormi Pulver White
- Department of Pediatrics, School of Medicine, Emory University, Atlanta, USA
- Marcus Autism Center, Children's Healthcare of Atlanta and Emory University, Atlanta, USA
| | - Jennifer G Mulle
- Center for Advanced Biotechnology and Medicine and Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, 679 Hoes Lane West, Piscataway, NJ, 08854, USA.
- Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, USA.
| |
Collapse
|